Deboudt C, Branchereau J, Luyckx F, Rigaud J, Glemain P, Blancho G, Karam G
Clinique urologique, CHU Hôtel-Dieu, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Prog Urol. 2012 Jun;22(7):402-7. doi: 10.1016/j.purol.2012.01.016. Epub 2012 Mar 3.
Portal veinous thrombosis (VT) in the pancreatic transplant (6 to 20% of the cases) is the first cause of early loss of the transplant. Our objective was to identify the risk factors of VT in our experiment.
The sample group includes 106 patients who underwent pancreas transplantation (portal venous drainage, enteric-drained pancreas) within our institute of transplantation from 2004 until 2010. We completed a portal vein extension graft in 25% of the cases. First of all, risk factors were selected from preoperative and operative data with an univariate analysis. We then carried out a multivariate analysis of these factors (binary logistic regression). The threshold P was 0.05.
Sixteen patients (15%) showed a VT. Eight of them developed a total thrombosis and required a transplantectomy. Three risk factors of VT were isolated by the multivariate analysis: a BMI of the receiver>25kg/m(2) (Odds Ratio [OR]=6.977), a portal vein extension graft (OR=4.1) and an age of the donor>45 years (OR=4.432).
The knowledge of these risk factors of thrombosis allows the implementation of preventive measures (selection of the donor, nutritional support of the receiver in the registration if BMI>25kg/m(2)). The portal lengthening should be avoided by an attentive retrieval of the transplant (without shorter section of the portal vein). Nevertheless, the presence of one of these risk factors in a transplant patient should lead to start an antithrombotic treatment.
胰腺移植中门静脉血栓形成(VT)(发生率为6%至20%)是移植早期失败的首要原因。我们的目的是在我们的实验中确定VT的危险因素。
样本组包括2004年至2010年在我们移植研究所接受胰腺移植(门静脉引流,肠道引流胰腺)的106例患者。25%的病例中我们完成了门静脉延长移植。首先,通过单因素分析从术前和手术数据中选择危险因素。然后我们对这些因素进行多因素分析(二元逻辑回归)。阈值P为0.05。
16例患者(15%)出现VT。其中8例发生完全血栓形成,需要进行移植切除。多因素分析分离出VT的三个危险因素:受者体重指数>25kg/m²(优势比[OR]=6.977)、门静脉延长移植(OR=4.1)和供者年龄>45岁(OR=4.432)。
了解这些血栓形成的危险因素有助于实施预防措施(选择供者,若体重指数>25kg/m²则在登记时对受者进行营养支持)。应通过仔细摘取移植器官(不缩短门静脉段)避免门静脉延长。然而,移植患者中存在这些危险因素之一应导致开始抗血栓治疗。